139 related articles for article (PubMed ID: 25199099)
1. Species-associated differences in the inhibition of propofol glucuronidation by magnolol.
Yang L; Zhu L; Ge G; Xiao L; Wu Y; Liang S; Cao Y; Yang L; Wang D
J Am Assoc Lab Anim Sci; 2014 Jul; 53(4):408-11. PubMed ID: 25199099
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
3. Species and sex differences in propofol glucuronidation in liver microsomes of humans, monkeys, rats and mice.
Mukai M; Isobe T; Okada K; Murata M; Shigeyama M; Hanioka N
Pharmazie; 2015 Jul; 70(7):466-70. PubMed ID: 26373207
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9.
Zhu L; Ge G; Liu Y; He G; Liang S; Fang Z; Dong P; Cao Y; Yang L
Xenobiotica; 2012 Oct; 42(10):1001-8. PubMed ID: 22591254
[TBL] [Abstract][Full Text] [Related]
5. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo.
Kim SB; Kim KS; Ryu HM; Hong SH; Kim BK; Kim DD; Park JW; Yoon IS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914211
[TBL] [Abstract][Full Text] [Related]
7. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
[TBL] [Abstract][Full Text] [Related]
8. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
[TBL] [Abstract][Full Text] [Related]
9. Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences.
Tian X; Liang S; Wang C; Wu B; Ge G; Deng S; Liu K; Yang L; Ma X
AAPS J; 2015 Jan; 17(1):156-66. PubMed ID: 25204783
[TBL] [Abstract][Full Text] [Related]
10. Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver.
Al-Jahdari WS; Yamamoto K; Hiraoka H; Nakamura K; Goto F; Horiuchi R
Eur J Clin Pharmacol; 2006 Jul; 62(7):527-33. PubMed ID: 16763826
[TBL] [Abstract][Full Text] [Related]
11. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
[TBL] [Abstract][Full Text] [Related]
12. Effects of propofol analogs on glucuronidation of propofol, an anesthetic drug, by human liver microsomes.
Shimizu M; Matsumoto Y; Yamazaki H
Drug Metab Lett; 2007 Jan; 1(1):77-9. PubMed ID: 19356023
[TBL] [Abstract][Full Text] [Related]
13. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
[TBL] [Abstract][Full Text] [Related]
15. Identification of human UDP-glucuronosyltransferase isoforms involved in the isofraxidin glucuronidation and assessment of the species differences of the reaction.
Meng F; Li Y; He G; Ge G; Liu S
Fitoterapia; 2017 Mar; 117():118-125. PubMed ID: 27915055
[TBL] [Abstract][Full Text] [Related]
16. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
Kaji H; Kume T
Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
[TBL] [Abstract][Full Text] [Related]
17. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
18. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of propofol and its analogs by human and rat liver microsomes.
Shimizu M; Matsumoto Y; Tatsuno M; Fukuoka M
Biol Pharm Bull; 2003 Feb; 26(2):216-9. PubMed ID: 12576683
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol can effectively accelerate estradiol-17-O-glucuronidation, while potently inhibiting estradiol-3-O-glucuronidation.
Zhu L; Xiao L; Xia Y; Zhou K; Wang H; Huang M; Ge G; Wu Y; Wu G; Yang L
Toxicol Appl Pharmacol; 2015 Mar; 283(2):109-16. PubMed ID: 25596428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
